Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
BRWD3
REST API REST API
Homo sapiens
BRWD3 is differentially expressed in 150 experiments: 73 organism parts: skeletal muscle, accumbens, ... (71 more);, 56 disease states: normal, control, ... (54 more);, 62 cell types 89 cell lines 17 compound treatments and 47 other conditions.
Synonyms FLJ38568, MRX93
Orthologs BRWD3 (Gallus gallus)   Brwd3 (Mus musculus)   BRWD3 (Bos taurus)   BRWD3 (Danio rerio)   D3Z8C5_RAT (Rattus norvegicus)   BRWD3 (Drosophila melanogaster)   BRWD3 (Canis familiaris)   Q28I59_XENTR (Xenopus laevis)   brwd3 (Xenopus laevis)   (Compare orthologs)
InterPro Term WD40_repeat_dom, WD40_repeat, Bromodomain, WD40_repeat_2, WD40_repeat_subgr
Gene Ontology Term protein binding
UniProt Accession Q6RI45
Gene-Disease Assocation MENTAL RETARDATION, X-LINKED 93; MRX93
Search EB-eye ENSG00000165288
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-GEOD-3526, ... (13 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-GEOD-20854, ... (21 experiments)

Factor Value U/D Experiments
MCF-7
1
2
E-GEOD-20081, E-GEOD-5823, E-GEOD-19639
RDES
1
E-MTAB-37
AsPC1
1
1
E-MTAB-37
NCIH2030
1
E-MTAB-37
NCIH522
1
E-MTAB-37
Hep3B
1
E-MTAB-37
83 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-22373, E-GEOD-21668, E-GEOD-20677, E-GEOD-4219, ... (30 experiments)

Factor Value U/D Experiments
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18265
mononuclear
2
E-GEOD-13987, E-GEOD-26672
macrophage
1
E-GEOD-22373
bronchial epithelial
1
E-AFMX-5
hMOF over-expressed
1
E-GEOD-20193
naive B cell
1
E-TABM-702
56 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-GEOD-15960, E-MEXP-882, E-MEXP-2069, ... (40 experiments)

Factor Value U/D Experiments
control
1
2
E-GEOD-21912, E-GEOD-8121, E-GEOD-16363
monoclonal gammopathy of uncertain significance
1
E-MTAB-372
cervical carcinoma
1
E-GEOD-5823
gulf war illness
1
E-MEXP-2069
lymph node metastasis
1
E-MEXP-882
neuroblastoma
1
E-MTAB-37
50 more value(s).


Compound treatment

studied in E-GEOD-3284, E-MEXP-2218, E-MEXP-1230, E-TABM-127, E-GEOD-6400, ... (12 experiments)

Factor Value U/D Experiments
CNOT7+CNOT8
1
1
E-MEXP-2218
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
TTA
1
1
E-MEXP-2590
unknown
1
E-GEOD-7307
TGF-Beta1
1
1
E-MEXP-2645
lipopolysaccharide
1
E-TABM-868
11 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22148, E-GEOD-21138

Environmental stress
studied in E-GEOD-4086

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-TABM-868, E-TABM-601, E-GEOD-17347, ... (6 experiments)

Growth condition
studied in E-TABM-127, E-GEOD-20540, E-MEXP-1103

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-TABM-666, E-GEOD-19519, ... (17 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-7179

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-1460

Population
studied in E-MTAB-197

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-19330, E-GEOD-10896

RNAi
studied in E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-12198

Processing time: 0.279 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM